Filter Results:
(1,011)
Show Results For
- All HBS Web
(2,065)
- People (8)
- News (601)
- Research (1,011)
- Events (3)
- Multimedia (26)
- Faculty Publications (607)
Show Results For
- All HBS Web
(2,065)
- People (8)
- News (601)
- Research (1,011)
- Events (3)
- Multimedia (26)
- Faculty Publications (607)
Sort by
- May 2025
- Case
Fidji Simo: Growing the Pie at Instacart
By: Hubert Joly, Leonard A. Schlesinger and James Barnett
In January 2025, Instacart CEO Fidji Simo considers strategies for continuing to grow Instacart from a grocery delivery platform to a holistic grocery technology company, including in-store grocery technology and expanding partnerships across the grocery sector. View Details
Keywords: Change Management; Transformation; Customers; Food; Health; Working Conditions; Leading Change; Operations; Going Public; Strategy; Growth and Development Strategy; Business or Company Management; Technology Industry; Technology Industry; United States; Canada
Joly, Hubert, Leonard A. Schlesinger, and James Barnett. "Fidji Simo: Growing the Pie at Instacart." Harvard Business School Case 325-052, May 2025.
- Article
Ein Booster für die Pharmabranche [A Booster for the Pharmaceutical Industry]
By: Ariel Dora Stern, Timo Minssen, W. Nicholson Price, II and Christoph Grimpe
mRNA technology has just helped to develop vaccines against COVID-19. Now, like Apple's iOS, it could provide the basis for new innovation platforms. View Details
Keywords: mRNA; COVID-19; Vaccines; Health Care and Treatment; Health Pandemics; Innovation and Invention; Health Industry
Stern, Ariel Dora, Timo Minssen, W. Nicholson Price, II, and Christoph Grimpe. "Ein Booster für die Pharmabranche [A Booster for the Pharmaceutical Industry]." Harvard Business Manager (July 2022).
- 08 Sep 2010
- First Look
First Look: September 8, 2010
under-invest in those firm attributes that may enhance long-term performance, such as human capital and technology (proxied by intangible assets in our paper). Indeed we do find evidence that ethnically Chinese firms invest far less in... View Details
Keywords: Sean Silverthorne
- November 2021 (Revised December 2021)
- Case
Praava Health: A New Model for Bangladesh
By: Michael Chu
Launched in Dhaka, Bangladesh, in 2018, Praava Health (‘Praava’) delivered high-quality in-clinic primary and specialist care, backed by its own high quality diagnostic laboratories, imaging and pharmacy. Praava was founder Sylvana Sinha’s response to what she saw as a... View Details
Keywords: Entrepreneurship; Health Care and Treatment; Investment Return; Mobile and Wireless Technology; Business Model; Growth and Development Strategy; Health Industry; Bangladesh; Asia
Chu, Michael. "Praava Health: A New Model for Bangladesh." Harvard Business School Case 322-067, November 2021. (Revised December 2021.)
- 31 Jul 2018
- First Look
New Research and Ideas, July 31, 2018
forthcoming Journal of Medical Internet Research Reimagining Health Data Exchange: An Application Programming Interface-Enabled Roadmap for India By: Balsari, Satchit, Alexander Fortenko MD, MPH, Joaquin A. Blaya PhD, Adrian Gropper MD,... View Details
Keywords: Dina Gerdeman
- October 2001
- Case
TIGR and ILRI: Solving Problems with Genomics
By: Ray A. Goldberg and James M Beagle
Discusses nonprofit institutional leadership applying advances in genetic science to solve health and animal problems in industrial countries and the developing world. View Details
- February 2025
- Article
Disclosure, Humanizing, and Contextual Vulnerability of Generative AI Chatbots
By: Julian De Freitas and I. Glenn Cohen
In the wake of recent advancements in generative AI, regulatory bodies are trying to keep pace. One key decision is whether to require app makers to disclose the use of generative AI-powered chatbots in their products. We suggest that some generative AI-based chatbots... View Details
Keywords: AI and Machine Learning; Governing Rules, Regulations, and Reforms; Applications and Software; Well-being
De Freitas, Julian, and I. Glenn Cohen. "Disclosure, Humanizing, and Contextual Vulnerability of Generative AI Chatbots." New England Journal of Medicine AI 2, no. 2 (February 2025).
- July 2003 (Revised August 2003)
- Case
Global Healthcare Exchange
By: Lynda M. Applegate and Jamie Ladge
Founded in March 2000 at the height of the dot-com bubble, Global Healthcare Exchange (GHX) was one of 90 online marketplaces in the health care industry. The company's founders were among the largest suppliers in the industry, including Johnson & Johnson, GE Medical,... View Details
Keywords: Mergers and Acquisitions; Entrepreneurship; Price; Leadership; Growth and Development Strategy; Supply and Industry; Organizational Design; Expansion; Internet and the Web; Valuation; Health Industry
Applegate, Lynda M., and Jamie Ladge. "Global Healthcare Exchange." Harvard Business School Case 804-002, July 2003. (Revised August 2003.)
- 2016
- Article
Integrated Care from the Patient's Perspective and its Relationship to Medical Group Attributes.
By: Michaela Kerrissey, Jonathan Clark, Ashley-Kay Fryer, Wei Jiang, Maryaline Catillon, Patricia Ramsay, Stephen Shortell, Lawrence Casalino, Mark Friedberg and Sara J. Singer
Integrating care for patients with multiple chronic conditions is essential to improving quality. Yet little is known about care integration from the patient’s perspective and how it relates to medical group characteristics. We created a nationally representative... View Details
Keywords: Care Coordination; Integrated Care; Health; Health Care and Treatment; Quality; Perspective; Health Industry
Kerrissey, Michaela, Jonathan Clark, Ashley-Kay Fryer, Wei Jiang, Maryaline Catillon, Patricia Ramsay, Stephen Shortell, Lawrence Casalino, Mark Friedberg, and Sara J. Singer. "Integrated Care from the Patient's Perspective and its Relationship to Medical Group Attributes." Academy of Management Proceedings (2016).
- 25 Feb 2015
- Lessons from the Classroom
Scholars and Students Unpack the Digital Business Revolution
in the music, news, and entertainment industries. The gathering will look at the emerging collaborative and sharing economies, explore organizational change in a digital context, consider the implications of new technologies for View Details
- February 2019 (Revised September 2019)
- Case
Theranos: The Unicorn That Wasn't
By: Joseph B. Fuller and John Masko
In 2003, 19-year-old Elizabeth Holmes founded a startup dedicated to making blood testing easier and more affordable. By 2015, her company, Theranos, was worth $9 billion. It boasted a star-studded board and contracts with national pharmacy and supermarket chains... View Details
Keywords: Theranos; Blood; Lab Testing; Fraud; Holmes; Balwani; Shultz; Carreyrou; Securities And Exchange Commission; Food And Drug Administration; FDA; SEC; Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Entrepreneurship; Medical Devices and Supplies Industry
Fuller, Joseph B., and John Masko. "Theranos: The Unicorn That Wasn't." Harvard Business School Case 319-068, February 2019. (Revised September 2019.)
- 2025
- Working Paper
Ultrasound Imaging--Cheap, Versatile, and Safe: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how efforts on multiple fronts, including advocacy, training, and technological development, made ultrasound the second most commonly used diagnostic imaging technology (after X-rays). Specifically, we chronicle 1) ultrasound’s development... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Ultrasound Imaging--Cheap, Versatile, and Safe: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-003, July 2019. (Revised January 2025.)
- 23 Mar 2020
- Research & Ideas
Product Disasters Can Be Fertile Ground for Innovation
technological complexity only magnifies the challenge. Many companies, meanwhile, are apt to see investment in safety as the cost of fulfilling regulatory requirements or protecting against lawsuits, rather than as an opportunity to... View Details
- 09 Aug 2016
- First Look
August 9, 2016
paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=51309 Innovation under Regulatory Uncertainty: Evidence from Medical Technology By: Stern, Ariel Dora Abstract—This paper explores how the regulatory approval process affects... View Details
Keywords: Sean Silverthorne
- 27 Aug 2013
- First Look
First Look: August 27
https://www.hbs.edu/faculty/Pages/item.aspx?num=45271 August 2013 Journal of Health Economics Consumers' Misunderstanding of Health Insurance By: Loewenstein, George, Joelle Y. Friedman, Barbara McGill, Sarah... View Details
Keywords: Sean Silverthorne
- Research Summary
Current Research
By: Leslie K. John
Professor John is a behavioral scientist who uses both laboratory and field experiments to investigate questions that are at the intersection of marketing, organizational behavior, and public policy.
Professor John’s work has been published in leading... View Details
- August 17, 2016
- Article
How a Cancer Center Rapidly Developed Patient-Centered Outcome Measures
By: Kevin P. Shah, Tracy E. Spinks and Thomas W. Feeley
In 2014, The University of Texas MD Anderson Cancer Center created a streamlined process for developing measure sets for patient-centered outcomes, including provider-generated and patient-reported outcomes, at an accelerated pace. These comprehensive sets are... View Details
Keywords: Information Technology; Measurement and Metrics; Quality; Service Delivery; Health Care and Treatment; Health Industry; Texas
Shah, Kevin P., Tracy E. Spinks, and Thomas W. Feeley. "How a Cancer Center Rapidly Developed Patient-Centered Outcome Measures." NEJM Catalyst (August 17, 2016).
- January 2024 (Revised April 2024)
- Case
Target Malaria: Editing Mosquitoes through Gene Drives
By: Shikhar Ghosh and Shweta Bagai
Target Malaria, a non-profit research consortium, is exploring the application of CRISPR-Cas9 gene editing technology to combat malaria in Sub-Saharan Africa. Its approach uses gene drives, a revolutionary tool, to suppress the population of malaria-carrying... View Details
Keywords: Health Disorders; Technological Innovation; Nonprofit Organizations; Business Strategy; Genetics; Ethics; Governing Rules, Regulations, and Reforms; United States; United Kingdom; Burkina Faso; Africa
Ghosh, Shikhar, and Shweta Bagai. "Target Malaria: Editing Mosquitoes through Gene Drives." Harvard Business School Case 824-068, January 2024. (Revised April 2024.)
- 31 Jul 2018
- Working Paper Summaries
How Does Product Liability Risk Affect Innovation? Evidence from Medical Implants
Keywords: by Alberto Galasso and Hong Luo